Aetion offers the world’s most advanced and fastest growing real-world evidence platform, accelerating the development and impact of treatments. Founded by Harvard Medical School faculty members and big data pioneers, Aetion helps biopharma and payers and, most importantly, patients thrive in the era of value-based care.

Sectors
Healthcare
Digital Health
First Invested
2018
Early
Company Status
Private
Associated Team
Michael Albert
Blake Wu